Nuveen Asset Management, LLC Soma Logic, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.76 - $2.83 $6,897 - $11,090	3,919 Added 0.96%	414,106 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$1.99 - $2.45 $8,847 - $10,892	-4,446 Reduced 1.07%	410,187 $980,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $83,568 - $141,242	-39,234 Reduced 8.64%	414,633 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $222,720 - $376,994	-108,644 Reduced 19.31%	453,867 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $24,691 - $214,385	39,193 Added 7.49%	562,511 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $2.23 Million - $4.32 Million	523,318 New	523,318 $2.37 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.